Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis
Recruiting
N/A
Interventional Study
Juvenile Idiopathic Arthritis (JIA)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 8 – 12
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 30 (estimated)
- Sponsor
- Istanbul University - Cerrahpasa · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Juvenile Idiopathic Arthritis (JIA) is the most common inflammatory, autoimmune, and chronic rheumatic disease of childhood (1). In individuals diagnosed with JIA, increased inflammation leads to joint swelling, tenderness, restricted range of motion, and pain (2,3). Over time, these symptoms may result in impaired movement and proprioception, reduced muscle strength, and gait abnormalities (2,3).…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Being between the ages of 8 and 13
* Having been diagnosed with JIA at least 6 months prior
* Willingness to participate in the study
Exclusion Criteria:
* Having a balance problem due to vestibular or neurological conditions
* Having undergone surgery in the last 6 months t…
Contacts